Summary
Anti-tumor vaccines are a relatively non-toxic alternative to conventional chemotherapeutic strategies to control breast cancer. Immunization with tumor-associated antigens (TAAs) triggers anti-tumor cytotoxic T lymphocytes (CTL), which can limit tumor progression. Here we report on the development and effectiveness of a TAA-based DNA vaccine encoding Mage-b1/2, the mouse homologue of the human MAGE-B1/2. As model system, we used immune competent Balb/c mice with syngeneic non-metastatic (64pT) or metastatic (4TO7cg) breast tumors. First, the presence of Mage-btranscripts in the 64pT and 4TO7cg breast tumors and metastases was demonstrated by RT-PCR, Southern blotting, and DNA sequencing. A DNA-based vaccine was developed from transcripts of one of the 64pT tumors, encoding the complete Mage-b1/2 protein, and subsequently tested for its preventive efficacy in both breast tumor models. Mice were immunized two times intramuscularly with the vaccine (pcDNA3.1-Mage-b1/2-V5), the control vector (pcDNA3.1-V5), or saline. Two weeks after the last immunization, the syngeneic 4TO7cg or 64pT tumor cell lines were injected in a mammary fat pad. Mice were monitored during the next 4 weeks for tumor formation, latency and size, and subsequently sacrificed for analysis. While the Mage-b1/2 vaccine had only a minor effect on the latency and growth of primary tumors, a significant and reproducible reduction in the number of 4TO7cg metastases was observed (vaccine versus control vector, p=0.0329; vaccine versus saline, p=0.0128). The observed protective efficacy of the Mage-b DNA vaccine correlated with high levels of vaccine-induced IFNγ in spleen and lymph nodes upon re-stimulation in vitro. These results demonstrate the potential of TAA-based DNA vaccines in controlling metastatic disease in breast cancer patients.
Similar content being viewed by others
References
JM Reichert C Paquette (2002) ArticleTitleTherapeutic cancer vaccines on trial Nat Biotechnol 20 659–663 Occurrence Handle10.1038/nbt0702-659 Occurrence Handle1:CAS:528:DC%2BD38XkvVGmurY%3D Occurrence Handle12089545
H Scarth J Cantin M Levine (2002) ArticleTitleClinical practice guidelines for the care and treatment of breast cancer: Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update) CMAJ 167 154–155 Occurrence Handle12160123
HA Pass SL Schwartz JR Wunderlich SA Rosenberg (1998) ArticleTitleImmunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay Cancer J Sci Am 4 316–323 Occurrence Handle1:STN:280:DyaK1M%2FjsFGisg%3D%3D Occurrence Handle9815296
S Calarota G Bratt S Nordlund J Hinkula AC Leandersson E Sandstrom B Wahren (1998) ArticleTitleCellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients Lancet 351 1320–1325 Occurrence Handle10.1016/S0140-6736(97)09440-3 Occurrence Handle1:STN:280:DyaK1czgsF2nug%3D%3D Occurrence Handle9643795
KE Ugen SB Nyland JD Boyer C Vidal L Lera S Rasheid M Chattergoon ML Bagarazzi R Ciccarelli T Higgins Y Baine R Ginsberg RR MacGregor DB. Weiner (1998) ArticleTitleDNA vaccination with HIV-1 expressing constructs elicits immune responses in humans Vaccine 19 1818–1821 Occurrence Handle10.1016/S0264-410X(98)00180-7
SW Krause C Neumann A Soruri S Mayer JH Peteres R Andreesen (2002) ArticleTitletreatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells J Immunother 25 421–428 Occurrence Handle10.1097/00002371-200209000-00006 Occurrence Handle1:CAS:528:DC%2BD38XntlyhtL4%3D Occurrence Handle12218780
M Marchand N Baren Particlevan P Weynants V Brichard B Dreno MH Tessier E Rankin G Parmiani F Arienti Y Humblet A Bourlond R Vanwijck D Lienard M Beauduin PY Dietrich V Russo J Kerger G Masucci E Jager J De Greve J Atzpodien F Brasseur PG Coulie P Bruggen Particlevan der T Boon (1999) ArticleTitleTumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1 Int J Cancer 80 219–230 Occurrence Handle10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S Occurrence Handle1:CAS:528:DyaK1MXhtlWqtw%3D%3D Occurrence Handle9935203
SA Rosenberg Zhai Y JC Yang DJ Schwartzentruber P Hwu FM Marincola SL Topalian NP Restifo CA Seipp JH Einhorn B Roberts DE White (1998) ArticleTitleImmunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens J Natl Cancer Inst 90 1984–1900 Occurrence Handle10.1093/jnci/90.24.1894
A Anichini A Molla R Mortarini G Tragni I Bersani M Di Nicola AM Gianni S Pillotti R Dunbar V Cerundolo G Parmiani (1999) ArticleTitleAn expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions J Exp Med 190 651–670 Occurrence Handle10.1084/jem.190.5.651 Occurrence Handle1:CAS:528:DyaK1MXlvFCitr8%3D Occurrence Handle10477550
PK Srivastava (2000) ArticleTitleImmunotherapy of human cancer: lessons from mice Nature Immunol 1 363–366 Occurrence Handle10.1038/80795 Occurrence Handle1:CAS:528:DC%2BD3cXnvVGhtr8%3D
Schreiber H: Tumor immunology. In: Paul W (ed) Fundamental Immunology. Lippincott-Raven, 1998, pp 1237–1270
C Gravekamp (2001) ArticleTitleTailoring cancer vaccines to the elderly: the importance of suitable mouse models Mech Ageing Dev 122 1087–1105 Occurrence Handle10.1016/S0047-6374(01)00252-4 Occurrence Handle1:CAS:528:DC%2BD3MXktVKktL0%3D Occurrence Handle11389926
JW Park TK Kwon IH Kim SS Sohn YS Kim CI Kim OS Bae KS Lee KD Lee CS Lee HK Chang BK Choe SY Ahn CH Jeon (2002) ArticleTitleA new strategy for the diagnosis of MAGE-expressing cancers J Immunol Meds 266 79–86 Occurrence Handle10.1016/S0022-1759(02)00105-9 Occurrence Handle1:CAS:528:DC%2BD38XlsVOktL4%3D
E De Plaen O De Backer D Arnaud B Bonjean P Chomez V Martelange P Avner P Baldacci C Babinet SY Hwang B Knowles T Boon (1999) ArticleTitleA new family of mouse genes homologous to the human MAGE genes Genomics 55 176–184 Occurrence Handle10.1006/geno.1998.5638 Occurrence Handle1:CAS:528:DyaK1MXhsVyisbY%3D Occurrence Handle9933564
O De Backer AM Verheyden B Martin D Godelaine E De Plaen R Brasseur P Avner T Boon (1995) ArticleTitleStructure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes Genomics 28 74–83 Occurrence Handle10.1006/geno.1995.1108 Occurrence Handle1:CAS:528:DyaK2MXnt1ejsLs%3D Occurrence Handle7590750
M Janitz D Fiszer J Jaruzelska AK Simon A Biro JA Sachs M Kurpisz (1993) ArticleTitleIn situ localization of HLA class I mRNA in human testis Exp Clin Immunogenet 10 202–207 Occurrence Handle1:CAS:528:DyaK2cXis1Oksr4%3D Occurrence Handle8136177
A Van Pel E De Plaen MT Duffour G Warnier C Uyttenhove M Perricaudet T Boon (2001) ArticleTitleInduction of cytolytic T lymphocytes by immunization with an adenovirus containing a mouse homolog of the human MAGE-A genes Cancer Immunol Immunother 49 593–602 Occurrence Handle10.1007/s002620000141 Occurrence Handle1:CAS:528:DC%2BD3MXit1eqsb4%3D Occurrence Handle11225990
RK Sypniewska L Hoflack DJ Bearss C Gravekamp (2002) ArticleTitlePotential mouse tumor model for pre-clinical testing of Mage-specific breast cancer vaccines Breast Cancer Res Treat 74 221–233 Occurrence Handle10.1023/A:1016367104015 Occurrence Handle1:CAS:528:DC%2BD38Xltlems74%3D Occurrence Handle12211215
FF Becker KM Klein SR Wolman R Asofsky S Sell (1973) ArticleTitleCharacterization of primary hepatocellular carcinomas and initial transplant generations Cancer Res 33 3330–3338 Occurrence Handle1:STN:280:CSuD2cfotVQ%3D Occurrence Handle4357361
JW Rak D McEachern FR Miller (1992) ArticleTitleSequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia Br J Cancer 65 641–648 Occurrence Handle1:CAS:528:DyaK38Xks1Olsrg%3D Occurrence Handle1586590
CJ Aslakson D McEachern H Conaway FR Miller (1991) ArticleTitleInhibition of lung colonization at two different steps in the metastatic sequence Clin Exp Metastases 9 139–150 Occurrence Handle1:STN:280:By6B3srlt1M%3D
FR Miller CJ Aslakson D McEachern (1991) ArticleTitleModulation of host resistance to metastasis in the lungs of aged retired breeder mice Invasion Metastasis 11 233–240 Occurrence Handle1:CAS:528:DyaK3sXhvV2ktL8%3D Occurrence Handle1765435
JP Reeves PA. Reeves (2003) Care and Handling of laboratory animals JE Coligan AM Kruisbeek DH Margulies EM Shevach W Strober (Eds) Current Protocols in Immunology Wiley New York 1–19
SF Altschul TL Madden AA Schaffer J Zhang Z Zhang W Miller DJ Lipman (1997) ArticleTitleGapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acid Res 25 3389–3402 Occurrence Handle10.1093/nar/25.17.3389 Occurrence Handle1:CAS:528:DyaK2sXlvFyhu7w%3D Occurrence Handle9254694
K Yasuda H Kawano I Yamane Y Ogawa T Yoshinaga M Nishikawa Y. Takakura (2004) ArticleTitleRestricted cytokine production from mouse peritoneal macrophages in culture in spite of extensive uptake of plasmid DNA Immunology 111 282–290 Occurrence Handle10.1111/j.1365-2567.2004.01814.x Occurrence Handle1:CAS:528:DC%2BD2cXitlGjtLs%3D Occurrence Handle15009428
C Gravekamp R Sypniewska S Gauntt M Tarango P Price R. Reddick (2004) ArticleTitleBehavior of metastatic and nonmetastatic breast tumors in old mice Exp Biol Med 229 665–675 Occurrence Handle1:CAS:528:DC%2BD2cXlslWqsb8%3D
TJ Curiel G Coukos L Zou X Alvarez P Cheng P Mottram M Evdemon-Hogan JR Conejo-Garcia L Zhang M Burrow Y Zhu S Wei I Kryczek B Daniel A Gordo A Myers ML Disis KL Knotson L Chen W. Zou (2004) ArticleTitleSpecific recruitment of regulatory T cells in ovarian carcinoma immune privilege and predicts reduced survival Nature Med 10 942–949 Occurrence Handle10.1038/nm1093 Occurrence Handle1:CAS:528:DC%2BD2cXntFSkt7g%3D Occurrence Handle15322536
AE Oran HL Robinson (2003) ArticleTitleDNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells J Immunol 171 1999–2005 Occurrence Handle1:CAS:528:DC%2BD3sXmtVWms7c%3D Occurrence Handle12902504
F Brasseur D Rimoldi D Lienard B Lethe S Carrel F Arienti L Suter R Vanwijck A Bourlond Y Humblet (1995) ArticleTitleExpression of MAGE genes in primary and metastatic cutaneous melanoma Int J Cancer 63 375–380 Occurrence Handle1:CAS:528:DyaK28XjslOr Occurrence Handle7591235
M Marchand CJA Punt S Aamdal B Escudier WHJ Kruit U Keilholz L Hakansson AMM Eggermont C Scheigenbogen J Uiters J Wanders M Delire T Boon G. Stoter (2003) ArticleTitleImmunization of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report Eur J Cancer 39 70–77 Occurrence Handle10.1016/S0959-8049(02)00479-3 Occurrence Handle1:CAS:528:DC%2BD38Xps12msLs%3D Occurrence Handle12504661
R Pardal MF Clarke SJ. Morrison (2003) ArticleTitleApplying the principles of stem cell biology to cancer Nature Rev Cancer 3 895–902 Occurrence Handle10.1038/nrc1232 Occurrence Handle1:CAS:528:DC%2BD3sXpvFahs7o%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sypniewska, R.K., Hoflack, L., Tarango, M. et al. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy. Breast Cancer Res Treat 91, 19–28 (2005). https://doi.org/10.1007/s10549-004-6454-7
Issue Date:
DOI: https://doi.org/10.1007/s10549-004-6454-7